Akebia Therapeutics is a pharmaceutical company, which focuses on treatments for ischemia and the improvement of vascular disease. It engages in the clinical development of compounds for the treatment of anemia and ischemia-related disorders. The Company offers Omacor for hypertriglyceridemia; and Actonel for osteoporosis. Its products include prolyl hydroxylase enzyme and phosphatase enzyme.